Literature DB >> 15215133

Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.

Young Uh1, In Ho Jang, Gyu Yel Hwang, Mi Kyung Lee, Kap Jun Yoon, Hyo Youl Kim.   

Abstract

In 540 beta-hemolytic streptococci, the rates of resistance to tetracycline, chloramphenicol, erythromycin, and clindamycin were 80.0, 22.8, 20.2, and 19.1%, respectively. Of the erythromycin-resistant isolates, 63.3% had the constitutive macrolide-lincosamide-streptogramin B (MLS(B)) resistance phenotype, 23.9% had the M phenotype, and 12.8% had the inducible MLS(B) resistance phenotype. The constitutive MLS(B) resistance phenotype with the erm(B) gene was dominant in Korea.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215133      PMCID: PMC434227          DOI: 10.1128/AAC.48.7.2716-2718.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Group B streptococcal disease: from trials and tribulations to triumph and trepidation.

Authors:  A Schuchat
Journal:  Clin Infect Dis       Date:  2001-08-10       Impact factor: 9.079

2.  High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors:  P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

3.  Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD.

Authors:  C Avanzini; K Bosio; G Volpe; G Dotti; D Savoia
Journal:  Microb Drug Resist       Date:  2000       Impact factor: 3.431

4.  Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.

Authors:  J Kataja; P Huovinen; M Skurnik; H Seppälä
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

5.  Different erythromycin resistance mechanisms in group C and group G streptococci.

Authors:  J Kataja; H Seppälä; M Skurnik; H Sarkkinen; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

6.  Susceptibility of beta-hemolytic streptococci to nine antimicrobial agents among four medical centers in Salt Lake City, Utah, USA.

Authors:  K C Carroll; P Monroe; S Cohen; M Hoffman; L Hamilton; K Korgenski; L Reimer; D Classen; J Daly
Journal:  Diagn Microbiol Infect Dis       Date:  1997-04       Impact factor: 2.803

7.  Drug resistance in Streptococcus pyogenes isolated in Japan.

Authors:  M Nakae; T Murai; Y Kaneko; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

8.  Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

Authors:  H Seppälä; A Nissinen; Q Yu; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

9.  High incidence of erythromycin-resistant streptococci in Taiwan.

Authors:  J J Wu; K Y Lin; P R Hsueh; J W Liu; H I Pan; S M Sheu
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

10.  Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

Authors:  J I Andrews; D J Diekema; S K Hunter; P R Rhomberg; M A Pfaller; R N Jones; G V Doern
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

View more
  7 in total

1.  Heterogeneity of genotype-phenotype correlation among macrolide-resistant Streptococcus agalactiae isolates.

Authors:  Ulrich von Both; Anna Buerckstuemmer; Kirsten Fluegge; Reinhard Berner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

3.  Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis.

Authors:  Ioanna N Grivea; Adnan Al-Lahham; George D Katopodis; George A Syrogiannopoulos; Ralf René Reinert
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae.

Authors:  Young Uh; Hyo Youl Kim; In Ho Jang; Gyu Yel Hwang; Kap Jun Yoon
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

5.  Genotyping of erythromycin resistant group C & G streptococci isolated in Chennai, south India.

Authors:  D Prabu; Thangam Menon
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

6.  Macrolide resistance trends in beta-hemolytic streptococci in a tertiary Korean hospital.

Authors:  Young Uh; Gyu Yel Hwang; In Ho Jang; Hyun Mi Cho; Song Mi Noh; Hyo Youl Kim; Ohgun Kwon; Kap Jun Yoon
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

7.  Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic viridans group streptococci in a tertiary Korean hospital.

Authors:  Young Uh; Gyu Yel Hwang; In Ho Jang; Ohgun Kwon; Hyo Youl Kim; Kap Jun Yoon
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.